| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00251-015-0888-4 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00251-015-0888-4 |
| P698 | PubMed publication ID | 26649563 |
| P2093 | author name string | Meixin Shen | |
| Ee-Chee Ren | |||
| Yeh-Ching Linn | |||
| P2860 | cites work | Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations | Q24612449 |
| NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis | Q24647094 | ||
| Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11 | Q27681802 | ||
| New allele frequency database: http://www.allelefrequencies.net | Q28204761 | ||
| UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells | Q28214601 | ||
| KIR3DL2: diversity in a hematopoietic stem cell transplant population | Q28238456 | ||
| Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. | Q29568902 | ||
| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 | ||
| Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer | Q29619483 | ||
| PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data | Q30772038 | ||
| PyPop update--a software pipeline for large-scale multilocus population genomics | Q30831137 | ||
| Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia | Q33378868 | ||
| Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity | Q33378871 | ||
| Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles | Q33740971 | ||
| Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors | Q33947906 | ||
| Acute myeloid leukemia, version 2.2013. | Q34165330 | ||
| Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia | Q34193507 | ||
| Acute myeloid leukaemia in adults | Q34327218 | ||
| The genomic context of natural killer receptor extended gene families | Q34341455 | ||
| The double life of NK receptors: stimulation or co-stimulation? | Q35617652 | ||
| Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules | Q35701077 | ||
| Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. | Q35828810 | ||
| MHC class I molecules and KIRs in human history, health and survival | Q36047157 | ||
| Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function | Q36228467 | ||
| In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans | Q36334393 | ||
| NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand | Q36813516 | ||
| Cooperating gene mutations in acute myeloid leukemia: a review of the literature. | Q37089717 | ||
| HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. | Q37157198 | ||
| The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia | Q37709339 | ||
| Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands | Q37885284 | ||
| Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse. | Q38973867 | ||
| Ex vivo activation of CD56(+) immune cells that eradicate neuroblastoma | Q39188737 | ||
| Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I. | Q40470350 | ||
| Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack? | Q40569017 | ||
| HLA-B locus sequence-based typing | Q40817594 | ||
| Natural killer cells modulation in hematological malignancies | Q41982546 | ||
| KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse. | Q44523558 | ||
| Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia | Q44553349 | ||
| Licensing of natural killer cells by host major histocompatibility complex class I molecules | Q46634172 | ||
| Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition | Q47817318 | ||
| NK cell education: not an on-off switch but a tunable rheostat. | Q51771715 | ||
| A novel real-time PCR method for KIR genotyping. | Q53424245 | ||
| Identification of natural killer cell receptor phenotypes associated with leukemia. | Q54698536 | ||
| Education of human natural killer cells by activating killer cell immunoglobulin-like receptors | Q61905881 | ||
| KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro | Q80582168 | ||
| The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations | Q81007095 | ||
| Association of KIR2DS4 and its variant KIR1D with leukemia | Q81234254 | ||
| An allelic typing method for 2DS4 variant used in study of haplotypes of killer cell immunoglobulin-like receptor gene | Q84195951 | ||
| Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma | Q87730660 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 133-144 | |
| P577 | publication date | 2015-12-09 | |
| P1433 | published in | Immunogenetics | Q15709984 |
| P1476 | title | KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patients | |
| P478 | volume | 68 |
| Q92130699 | Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study |
| Q38703075 | KIR3DL1/ HL A-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation. |
| Q49566331 | NK cell therapy for hematologic malignancies. |
| Q92404977 | Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han |
| Q47590707 | The progress and current status of immunotherapy in acute myeloid leukemia |
Search more.